27475696|t|Estrogen and Progesterone hormone receptor expression in oral cavity cancer
27475696|a|Recent studies have shown an increase in the incidence of oral squamous cell carcinoma (OSCC) in younger patients. The hypothesis that tumors could be hormonally induced during pregnancy or in young female patients without the well-known risk factors alcohol or tobacco abuse seems to be plausible. Estrogen Receptor alpha (ERα) and Progesterone Receptor (PR) expression were analyzed in normal oral mucosa (n=5), oral precursor lesions (simple hyperplasia, n=11; squamous intraepithelial neoplasia, SIN I-III, n=35), and OSCC specimen. OSCCs were stratified in a young female (n=7) study cohort and older patients (n=46). In the young female study cohort three patients (n=3/7) developed OSCC during or shortly after pregnancy. Breast cancer tissues were used as positive control for ERα and PR expression. ERα expression was found in four oral precursor lesions (squamous intraepithelial neoplasia, SIN I-III, n=4/35, 11%) and in five OSCC specimen (n=5/46, 11%). The five ERα positive OSCC samples were older male patients. All patients within the young female study cohort were negatively stained for both ERα and PR. ER expression could be regarded as a seldom risk factor for OSCC. PR expression seems to be not relevant for the development of OSCC.
27475696	0	8	Estrogen	T103	UMLS:C0014939
27475696	13	25	Progesterone	T103	UMLS:C0033308
27475696	26	33	hormone	T103	UMLS:C0019932
27475696	57	75	oral cavity cancer	T038	UMLS:C0151546
27475696	134	162	oral squamous cell carcinoma	T038	UMLS:C0585362
27475696	164	168	OSCC	T038	UMLS:C0585362
27475696	211	217	tumors	T038	UMLS:C0027651
27475696	227	237	hormonally	T103	UMLS:C0019932
27475696	253	262	pregnancy	T038	UMLS:C0032961
27475696	314	326	risk factors	T033	UMLS:C0035648
27475696	327	334	alcohol	T038	UMLS:C0085762
27475696	338	351	tobacco abuse	T038	UMLS:C0040336
27475696	375	398	Estrogen Receptor alpha	T103	UMLS:C0665341
27475696	400	403	ERα	T103	UMLS:C0665341
27475696	409	430	Progesterone Receptor	T103	UMLS:C0034833
27475696	432	434	PR	T103	UMLS:C0034833
27475696	452	460	analyzed	T062	UMLS:C0936012
27475696	471	482	oral mucosa	T017	UMLS:C0026639
27475696	490	512	oral precursor lesions	T033	UMLS:C0221198
27475696	514	532	simple hyperplasia	T038	UMLS:C0456483
27475696	540	574	squamous intraepithelial neoplasia	T038	UMLS:C1302751
27475696	576	585	SIN I-III	T038	UMLS:C1302751
27475696	598	602	OSCC	T038	UMLS:C0585362
27475696	613	618	OSCCs	T038	UMLS:C0585362
27475696	665	671	cohort	T098	UMLS:C0599755
27475696	725	731	cohort	T098	UMLS:C0599755
27475696	765	769	OSCC	T038	UMLS:C0585362
27475696	794	803	pregnancy	T038	UMLS:C0032961
27475696	805	818	Breast cancer	T038	UMLS:C0678222
27475696	819	826	tissues	T017	UMLS:C0040300
27475696	861	864	ERα	T103	UMLS:C0665341
27475696	869	871	PR	T103	UMLS:C0034833
27475696	884	887	ERα	T103	UMLS:C0665341
27475696	917	939	oral precursor lesions	T033	UMLS:C0221198
27475696	941	975	squamous intraepithelial neoplasia	T038	UMLS:C1302751
27475696	977	986	SIN I-III	T038	UMLS:C1302751
27475696	1013	1017	OSCC	T038	UMLS:C0585362
27475696	1051	1054	ERα	T103	UMLS:C0665341
27475696	1055	1063	positive	T033	UMLS:C1446409
27475696	1064	1068	OSCC	T038	UMLS:C0585362
27475696	1146	1152	cohort	T098	UMLS:C0599755
27475696	1158	1168	negatively	T033	UMLS:C0205160
27475696	1186	1189	ERα	T103	UMLS:C0665341
27475696	1194	1196	PR	T103	UMLS:C0034833
27475696	1198	1200	ER	T103	UMLS:C0034804
27475696	1242	1253	risk factor	T033	UMLS:C0035648
27475696	1258	1262	OSCC	T038	UMLS:C0585362
27475696	1264	1266	PR	T103	UMLS:C0034833
27475696	1326	1330	OSCC	T038	UMLS:C0585362